Exact Sciences
EXAS
#1383
Rank
S$17.04 B
Marketcap
$92.26
Share price
2.34%
Change (1 day)
-10.31%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of June 2024 : S$1.23 B

According to Exact Sciences's latest financial reports the company has S$1.23 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$1.02 B21.21%
2022-12-31S$0.84 B-39.03%
2021-12-31S$1.38 B-42.87%
2020-12-31S$2.43 B458.92%
2019-12-31S$0.43 B-71.58%
2018-12-31S$1.53 B169.59%
2017-12-31S$0.56 B26.16%
2016-12-31S$0.45 B3.63%
2015-12-31S$0.43 B16.3%
2014-12-31S$0.37 B121.24%
2013-12-31S$0.16 B27.63%
2012-12-31S$0.13 B9.43%
2011-12-31S$0.12 B-1.67%
2010-12-31S$0.12 B259.66%
2009-12-31S$34.18 M381.56%
2008-12-31S$7.09 M-60.99%
2007-12-31S$18.19 M-43.68%
2006-12-31S$32.31 M-43.11%
2005-12-31S$56.8 M-23.38%
2004-12-31S$74.14 M56.66%
2003-12-31S$47.32 M-37.79%
2002-12-31S$76.07 M-27.7%
2001-12-31S$0.10 B129.37%
2000-12-31S$45.87 M675.44%
1999-12-31S$5.91 M-59.4%
1998-12-31S$14.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.12 B-89.72%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.30 B-75.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.63 M-99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.48 B 669.36%๐Ÿ‡ซ๐Ÿ‡ท France